DDX41_HUMAN - dbPTM
DDX41_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DDX41_HUMAN
UniProt AC Q9UJV9
Protein Name Probable ATP-dependent RNA helicase DDX41
Gene Name DDX41
Organism Homo sapiens (Human).
Sequence Length 622
Subcellular Localization Nucleus .
Protein Description Probable ATP-dependent RNA helicase. Is required during post-transcriptional gene expression. May be involved in pre-mRNA splicing..
Protein Sequence MEESEPERKRARTDEVPAGGSRSEAEDEDDEDYVPYVPLRQRRQLLLQKLLQRRRKGAAEEEQQDSGSEPRGDEDDIPLGPQSNVSLLDQHQHLKEKAEARKESAKEKQLKEEEKILESVAEGRALMSVKEMAKGITYDDPIKTSWTPPRYVLSMSEERHERVRKKYHILVEGDGIPPPIKSFKEMKFPAAILRGLKKKGIHHPTPIQIQGIPTILSGRDMIGIAFTGSGKTLVFTLPVIMFCLEQEKRLPFSKREGPYGLIICPSRELARQTHGILEYYCRLLQEDSSPLLRCALCIGGMSVKEQMETIRHGVHMMVATPGRLMDLLQKKMVSLDICRYLALDEADRMIDMGFEGDIRTIFSYFKGQRQTLLFSATMPKKIQNFAKSALVKPVTINVGRAGAASLDVIQEVEYVKEEAKMVYLLECLQKTPPPVLIFAEKKADVDAIHEYLLLKGVEAVAIHGGKDQEERTKAIEAFREGKKDVLVATDVASKGLDFPAIQHVINYDMPEEIENYVHRIGRTGRSGNTGIATTFINKACDESVLMDLKALLLEAKQKVPPVLQVLHCGDESMLDIGGERGCAFCGGLGHRITDCPKLEAMQTKQVSNIGRKDYLAHSSMDF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MEESEPERKRA
----CCCCHHHHHHC
45.1829255136
9SumoylationEESEPERKRARTDEV
CCCHHHHHHCCCCCC
49.07-
9SumoylationEESEPERKRARTDEV
CCCHHHHHHCCCCCC
49.07-
13PhosphorylationPERKRARTDEVPAGG
HHHHHCCCCCCCCCC
35.2123927012
21PhosphorylationDEVPAGGSRSEAEDE
CCCCCCCCCCCCCCC
31.5429255136
23PhosphorylationVPAGGSRSEAEDEDD
CCCCCCCCCCCCCCC
42.7419664994
33PhosphorylationEDEDDEDYVPYVPLR
CCCCCCCCCCCCCHH
10.9823927012
36PhosphorylationDDEDYVPYVPLRQRR
CCCCCCCCCCHHHHH
12.4923927012
49UbiquitinationRRQLLLQKLLQRRRK
HHHHHHHHHHHHHHC
51.6521890473
56AcetylationKLLQRRRKGAAEEEQ
HHHHHHHCCHHHHHH
51.6026051181
66PhosphorylationAEEEQQDSGSEPRGD
HHHHHHCCCCCCCCC
39.6229255136
68PhosphorylationEEQQDSGSEPRGDED
HHHHCCCCCCCCCCC
48.6729255136
71MethylationQDSGSEPRGDEDDIP
HCCCCCCCCCCCCCC
62.23-
83PhosphorylationDIPLGPQSNVSLLDQ
CCCCCCCCCCHHHHH
42.1923927012
86PhosphorylationLGPQSNVSLLDQHQH
CCCCCCCHHHHHHHH
27.7123403867
95UbiquitinationLDQHQHLKEKAEARK
HHHHHHHHHHHHHHH
55.85-
111SumoylationSAKEKQLKEEEKILE
HHHHHHHHHHHHHHH
61.66-
111SumoylationSAKEKQLKEEEKILE
HHHHHHHHHHHHHHH
61.66-
115UbiquitinationKQLKEEEKILESVAE
HHHHHHHHHHHHHHH
56.74-
128PhosphorylationAEGRALMSVKEMAKG
HHHHHHHCHHHHHCC
30.7824719451
130AcetylationGRALMSVKEMAKGIT
HHHHHCHHHHHCCCC
34.1725953088
130UbiquitinationGRALMSVKEMAKGIT
HHHHHCHHHHHCCCC
34.17-
138PhosphorylationEMAKGITYDDPIKTS
HHHCCCCCCCCCCCC
19.21-
143UbiquitinationITYDDPIKTSWTPPR
CCCCCCCCCCCCCCC
41.72-
145PhosphorylationYDDPIKTSWTPPRYV
CCCCCCCCCCCCCEE
24.7730631047
147PhosphorylationDPIKTSWTPPRYVLS
CCCCCCCCCCCEEEC
24.1521815630
154PhosphorylationTPPRYVLSMSEERHE
CCCCEEECCCHHHHH
15.3730631047
156PhosphorylationPRYVLSMSEERHERV
CCEEECCCHHHHHHH
32.6920860994
182PhosphorylationGIPPPIKSFKEMKFP
CCCCCCCCHHHCCCH
42.1224719451
194MethylationKFPAAILRGLKKKGI
CCHHHHHHHHHHCCC
42.14-
199UbiquitinationILRGLKKKGIHHPTP
HHHHHHHCCCCCCCC
62.60-
232PhosphorylationAFTGSGKTLVFTLPV
EECCCCCEEEEEHHH
31.5124114839
236PhosphorylationSGKTLVFTLPVIMFC
CCCEEEEEHHHHHHH
23.7524114839
254UbiquitinationEKRLPFSKREGPYGL
HCCCCCCCCCCCCEE
55.64-
259PhosphorylationFSKREGPYGLIICPS
CCCCCCCCEEEECCC
35.1128152594
288PhosphorylationCRLLQEDSSPLLRCA
HHHHHCCCCHHHHHH
32.8627966365
289PhosphorylationRLLQEDSSPLLRCAL
HHHHCCCCHHHHHHH
31.7126699800
302PhosphorylationALCIGGMSVKEQMET
HHHHCCCCHHHHHHH
33.0624719451
320PhosphorylationGVHMMVATPGRLMDL
CCCEEECCHHHHHHH
18.1823312004
330UbiquitinationRLMDLLQKKMVSLDI
HHHHHHHHHCCCHHH
42.69-
330AcetylationRLMDLLQKKMVSLDI
HHHHHHHHHCCCHHH
42.6925953088
331UbiquitinationLMDLLQKKMVSLDIC
HHHHHHHHCCCHHHH
31.41-
331AcetylationLMDLLQKKMVSLDIC
HHHHHHHHCCCHHHH
31.4127452117
364PhosphorylationDIRTIFSYFKGQRQT
CHHHHHHHHCCCCEE
9.88-
366MethylationRTIFSYFKGQRQTLL
HHHHHHHCCCCEEEE
45.99-
381UbiquitinationFSATMPKKIQNFAKS
EECCCCHHHHHHHHH
43.59-
388PhosphorylationKIQNFAKSALVKPVT
HHHHHHHHHCCCCEE
24.3320860994
392SumoylationFAKSALVKPVTINVG
HHHHHCCCCEEEECC
34.32-
392SumoylationFAKSALVKPVTINVG
HHHHHCCCCEEEECC
34.32-
392UbiquitinationFAKSALVKPVTINVG
HHHHHCCCCEEEECC
34.32-
395PhosphorylationSALVKPVTINVGRAG
HHCCCCEEEECCCCC
18.50-
405PhosphorylationVGRAGAASLDVIQEV
CCCCCCCCCHHHHHH
25.2728348404
414PhosphorylationDVIQEVEYVKEEAKM
HHHHHHHHHHHHHHH
23.23-
416UbiquitinationIQEVEYVKEEAKMVY
HHHHHHHHHHHHHHH
49.27-
416SumoylationIQEVEYVKEEAKMVY
HHHHHHHHHHHHHHH
49.27-
416SumoylationIQEVEYVKEEAKMVY
HHHHHHHHHHHHHHH
49.2728112733
416AcetylationIQEVEYVKEEAKMVY
HHHHHHHHHHHHHHH
49.2725953088
4412-HydroxyisobutyrylationPVLIFAEKKADVDAI
CEEEEECCCCCHHHH
50.24-
442UbiquitinationVLIFAEKKADVDAIH
EEEEECCCCCHHHHH
41.13-
442SumoylationVLIFAEKKADVDAIH
EEEEECCCCCHHHHH
41.13-
442SumoylationVLIFAEKKADVDAIH
EEEEECCCCCHHHHH
41.1328112733
455UbiquitinationIHEYLLLKGVEAVAI
HHHHHHHHCCEEEEE
61.96-
466UbiquitinationAVAIHGGKDQEERTK
EEEECCCCCHHHHHH
61.91-
473UbiquitinationKDQEERTKAIEAFRE
CCHHHHHHHHHHHHH
54.29-
482UbiquitinationIEAFREGKKDVLVAT
HHHHHHCCCCEEEEE
40.84-
493PhosphorylationLVATDVASKGLDFPA
EEEEHHHCCCCCCCH
27.4024114839
523PhosphorylationYVHRIGRTGRSGNTG
HHHHHCCCCCCCCCC
31.5620068231
526PhosphorylationRIGRTGRSGNTGIAT
HHCCCCCCCCCCEEH
37.4320068231
529PhosphorylationRTGRSGNTGIATTFI
CCCCCCCCCEEHHHH
33.2328509920
533PhosphorylationSGNTGIATTFINKAC
CCCCCEEHHHHHHHC
21.9620068231
534PhosphorylationGNTGIATTFINKACD
CCCCEEHHHHHHHCC
17.3128509920
538UbiquitinationIATTFINKACDESVL
EEHHHHHHHCCHHHH
45.64-
549UbiquitinationESVLMDLKALLLEAK
HHHHHHHHHHHHHHH
32.49-
556UbiquitinationKALLLEAKQKVPPVL
HHHHHHHHHHCCCEE
41.08-
572PhosphorylationVLHCGDESMLDIGGE
EEEECCHHHCCCCCC
29.4130576142
597UbiquitinationHRITDCPKLEAMQTK
CCCCCCHHHHHHHCC
66.35-
603PhosphorylationPKLEAMQTKQVSNIG
HHHHHHHCCCCCCCC
15.4522673903
604UbiquitinationKLEAMQTKQVSNIGR
HHHHHHCCCCCCCCC
31.63-
612UbiquitinationQVSNIGRKDYLAHSS
CCCCCCCCHHHHHCC
45.58-
614PhosphorylationSNIGRKDYLAHSSMD
CCCCCCHHHHHCCCC
14.6026270265
618PhosphorylationRKDYLAHSSMDF---
CCHHHHHCCCCC---
23.0425159151
619PhosphorylationKDYLAHSSMDF----
CHHHHHCCCCC----
16.7125159151

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
414YPhosphorylationKinaseBTKQ06187
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DDX41_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DDX41_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NKAP_HUMANNKAPphysical
22365833
CEP70_HUMANCEP70physical
25416956
CLVS2_HUMANCLVS2physical
26344197
PREP_HUMANPITRM1physical
26344197
ANR50_HUMANANKRD50physical
28514442
CSK21_HUMANCSNK2A1physical
28514442
CAPON_HUMANNOS1APphysical
28514442
PININ_HUMANPNNphysical
28514442
SIN3A_HUMANSIN3Aphysical
28514442
SRRM2_HUMANSRRM2physical
28514442
RNPS1_HUMANRNPS1physical
28514442
BRM1L_HUMANBRMS1Lphysical
28514442
CBY1_HUMANCBY1physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DDX41_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-23, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-23, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-23, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-23, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND SER-23, AND MASSSPECTROMETRY.

TOP